MedTrace Logo

Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation

NCT02487797 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1003

Last updated 2022-02-11

Study results available
· View outcomes & findings →

Summary

Oxytocin is a medication that is often used to strengthen contractions to overcome delayed labor progress. The primary aim of this study is to determine whether receiving a higher dose of oxytocin lowers the chance of needing a cesarean section when compared to a lower dose of oxytocin. Other aims include examining the relationship between dose of oxytocin regimen and length of labor, postpartum hemorrhage, intrauterine infection, umbilical cord gas, neonatal Apgar score \<5 at 5 minutes, and need for neonatal intensive care.

Conditions

  • Dystocia

Interventions

DRUG

Oxytocin

OTHER

Sodium Chloride 0.9%

Sponsors & Collaborators

Principal Investigators

  • Moeun Son, MD, MSCI · Northwestern University

  • Alan Peaceman, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-28
Primary Completion
2020-09-01
Completion
2020-09-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02487797 on ClinicalTrials.gov